Table 3. Comparison of clinical–pathological parameters in the two groups of nasopharyngeal carcinoma.
| Classification | Radioresistant group(n = 30) | Radiosensitive group(n = 30) | *p | |
|---|---|---|---|---|
| Pathologic type | Differentiated | 5 | 6 | >0.05 |
| Undifferentiated | 25 | 24 | ||
| T Stage | T1 | 2 | 3 | >0.05 |
| T2 | 4 | 10 | ||
| T3 | 9 | 6 | ||
| T4 | 15 | 11 | ||
| N Stage | N0 | 0 | 0 | >0.05 |
| N1 | 15 | 10 | ||
| N2 | 13 | 16 | ||
| N3 | 2 | 4 | ||
| Clinical stage | I | 0 | 0 | >0.05 |
| II | 3 | 6 | ||
| III | 11 | 9 | ||
| IVa+IVb | 16 | 15 | ||
| Sex | Male | 20 | 25 | >0.05 |
| Female | 10 | 5 | ||
| Age | <50 | 17 | 16 | >0.05 |
| ≥50 | 13 | 14 | ||
| Hemoglobin (g/L) | 132.6 ± 16.89 | 131.50 ± 16.30 | >0.05 | |
| GTVnx (Gy) | 71.76 ± 0.92 | 71.52 ± 1.05 | >0.05 | |
| GTVnd (Gy) | 68.34 ± 1.80 | 68.25 ± 2.69 | >0.05 | |
| CTV1 (Gy) | 60.73 ± 0.98 | 60.33 ± 0.78 | >0.05 | |
| CTV2 (Gy) | 54.66 ± 0.88 | 54.23 ± 0.80 | >0.05 |
* The difference between the two groups was not statistically significant.